Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Dublin, Feb. 23, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical) has announced the addition of the "Biopharmaceutical Bioseparation Systems - Global Strategic Analysis" report to their offering.
This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments: Chromatography Systems, and Other Bioseparation Systems.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 52 companies including many key and niche players such as:
- 3M Company (US)
- 3M Purification, Inc. (US)
- Agilent Technologies, Inc. (US)
- Alfa Wassermann Separation Technologies, LLC (US)
- Flottweg Separation Technology (US)
- GEA Westfalia Separator Group GmbH (Germany)
- GE Healthcare (UK)
- KNAUER Wissenschaftliche Geräte GmbH (Germany)
- Konik Nanobiotech SL (Spain)
- Merck KGaA (Germany)
- NuSep Holdings Ltd. (Australia)
- Pall Corporation (US)
- ProMetic Life Sciences, Inc. (Canada)
- Sartorius Stedim Biotech (France)
- Spectrum Laboratories, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- Tosoh Bioscience, Inc. (Japan)
- YMC Europe GmbH (Germany)
Key Topics Covered:
1. Outlook
2. Industry Overview
3. Bioseparation Technologies - Key Trends
4. Product Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 52 (including Divisions/Subsidiaries 60)
- The United States (32)
- Canada (1)
- Japan (5)
- Europe (18)
- - France (3)
- - Germany (9)
- - The United Kingdom (1)
- - Spain (1)
- - Rest of Europe (4)
- Asia-Pacific (Excluding Japan) (4)
For more information visit http://www.researchandmarkets.com/research/7qc9v5/biopharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
